Hot Penny Stocks! Don't get burned!
Home
Products
Message boards
Newsletters
Canadian Stocks
Research
June 19 2013 01:05 PM ET - till market close: 02:55
Home
>
Companies
>
Abiomed, Inc
>
Recent Material Events
More
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Message Board
HYPE REPORT
Top 20 Most Heavily Promoted Penny Stocks For June 2013
Pink Sheets
USEI
Us Energy Initiatives ...
FITX
Creative Edge Nutritio...
CCTC
Clean Coal Technologie...
PGVI
Promithian Global Vent...
DRGV
Dragon Capital Group C...
PTOG
Petrotech Oil & Gas, Inc.
CEHC
Cephas Holding Corp.
PMEA
Pm&e, Inc.
RRHI
Raptor Resources Holdi...
MISM
Mission Mining Co
OTC BB
RJDG
RJD Green Inc.
TALK
iTalk, Inc.
VTMB
Vitamin Blue Inc
INOL
InoLife Technologies, ...
TRTC
Terra Tech Corp.
GLDN
Gold Dynamics Corp.
QLTS
QLOTUS HOLDINGS INC
TQLA
Montalvo Spirits, Inc.
OLIE
Olie Inc.
PLSB
The Pulse Beverage Corp.
BROWSE COMPANIES
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
0
1
2
3
4
5
6
7
8
9
Abiomed, Inc (ABMD)
Watch the video to learn about the probability of
Abiomed, Inc (ABMD)
Chart Signal as of
Jun 19 2013
Hotstocked Precision will calculate the probabilities of
Abiomed, Inc (ABMD)
Rating:
Size:
656KB
Version:
1.1
Platform:
Win/Mac
Downloads:
FREE DOWNLOAD
Filing Date
Description
2012-12-07
Dr. David Weber our Chief Operating Officer, Dr. Jeffrey Popma of Beth Israel Deaconess Medical Center in Boston and Dr. William O’Neill of Henry Ford Hospital led a presentation to the FDA’s Circulatory System Devices Panel related to the ...
2012-12-07
Dr. David Weber our Chief Operating Officer, Dr. Jeffrey Popma of Beth Israel Deaconess Medical Center in Boston and Dr. William O’Neill of Henry Ford Hospital led a presentation to the FDA’s Circulatory System Devices Panel related to the ...
2012-11-19
On November 16, 2012, we issued a press release announcing that our Company and certain of our executives have been named as defendants in a purported class action complaint. A copy of the press release is attached as Exhibit 99.1 to this current rep ...
2012-11-19
On November 16, 2012, we issued a press release announcing that our Company and certain of our executives have been named as defendants in a purported class action complaint. A copy of the press release is attached as Exhibit 99.1 to this current rep ...
2012-11-13
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ...
2012-11-13
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ...
2012-11-01
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ...
2012-09-21
Abiomed is filing this current report on Form 8-K in response to recent investor questions received at a series of investor conferences and meetings over the past several weeks. ...
2012-09-21
Abiomed is filing this current report on Form 8-K in response to recent investor questions received at a series of investor conferences and meetings over the past several weeks. ...
2012-09-12
The Impella CP provides peak flows of approximately four liters of blood per minute and is indicated for up to six hours of partial circulatory support using an extracorporeal bypass control unit. It is also intended to be used to provide partial cir ...
